tiprankstipranks
NexImmune (NEXI)
OTHER OTC:NEXI
US Market

NexImmune (NEXI) Income Statement

Compare
161 Followers

NexImmune Income Statement

Last quarter (Q2 2024), NexImmune's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, NexImmune's net income was $-2.33M. See NexImmune’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.02M$ -1.50M$ -870.28K$ -618.99K$ -436.37K
Operating Expenses
$ 28.17M$ 63.08M$ 53.26M$ 27.85M$ 20.89M
Depreciation and Amortization
$ 1.02M$ 1.50M$ 870.28K$ 618.99K$ 436.37K
EBITDA
$ -28.17M$ -61.59M$ -52.39M$ -27.12M$ -20.45M
Operating Income
$ -29.19M$ -63.08M$ -53.26M$ -27.85M$ -20.89M
Other Income/Expenses
$ -3.15M$ 576.69K$ 2.35M$ -2.01M$ 339.06K
Pretax Income
$ -32.34M$ -62.51M$ -50.90M$ -29.87M$ -20.55M
Net Income
$ -32.34M$ 514.18M$ -51.75M$ -31.64M$ -20.30M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -30.82$ 534.29$ -56.67$ -34.76$ -22.53
Diluted EPS
$ -30.82$ 534.29$ -56.67$ -34.76$ -22.53
Weighted Average Shares Outstanding
1.05M 962.36K 913.16K 910.31K 900.86K
Weighted Average Shares Outstanding (Diluted)
1.05M 962.36K 913.16K 910.31K 900.86K
Currency in USD

NexImmune Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis